Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
16 More recently, the FLOW trial enrolled 3,533 patients with T2D and CKD (estimated glomerular filtration rate [eGFR] 5075 ml/min/1.73 m 2 with an albumin-to-creatinine ratio of 3005,000 or eGFR 2549 ml/min/1.73 m 2 with an albumin-to-creatinine ratio of 1005,000)
This ensures our clients receive a reliable product for their research needs, supporting advanced studies and innovative applications
The progression of CKD can lead to end-stage renal disease (ESRD), increasing the risk of kidney failure with a need for renal replacement therapy involving dialysis or renal transplant
Rolland, C
US$ 28.36
US$ 23.06
US$ 23.26
US$ 22.48
US$ 26.56
US$ 22.07
US$ 20.68
